research use only
Cat.No.S7391
| Related Targets | HDAC Caspase Proteasome Secretase MMP HCV Protease DPP Tyrosinase HIV Protease Serine Protease |
|---|---|
| Other Cysteine Protease Inhibitors | N-Ethylmaleimide (NEM) MG132 SSS Calpeptin Aloxistatin (E-64d) Odanacatib E-64 MG-101 (ALLN) Cathepsin Inhibitor 1 PD 151746 Loxistatin Acid (E-64C) |
| Molecular Weight | 386.42 | Formula | C21 H23 F N2 O4 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 197855-65-5 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | (1S)-Z-FA-FMK | Smiles | CC(C(=O)CF)NC(=O)C(CC1=CC=CC=C1)NC(=O)OCC2=CC=CC=C2 | ||
|
In vitro |
DMSO
: 77 mg/mL
(199.26 mM)
Ethanol : 48 mg/mL Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Targets/IC50/Ki |
cysteine protease
|
|---|---|
| In vitro |
Z-FA-FMK inhibits the degradation of fibrillar collagen by fibroblasts and osteoclasts. This compound inhibits LPS-induced cytokine production via inhibition of NF-kappaB-dependent gene expression in macrophages. It efficiently blocks T cell proliferation induced by mitogens and IL-2 in vitro.
|
| In vivo |
Z-FA-FMK significantly increases pneumococcal growth in both lungs and blood in a mouse model of intranasal pneumococcal infection. This compound blocks reovirus infection of Ras oncogenic tumours and host heart tissues in severe combined immunodeficiency mice.
|
References |
|
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.